Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis

Summary

This Phase II study is to evaluate the efficacy of SR-T100 gel with 2.3% of SM in Solanum undatum plant extract in patient with Actinic Keratosis (AK).

Timeline

Start

2013-02

Primary completion

2017-12

Completion

2018-10

Drugs

Indications